404: Page not Found
To find an doctor profile, first select a location from the home page and then search.
If you can't find the page you're looking for using the navigation above, please Contact Us.
To find an doctor profile, first select a location from the home page and then search.
If you can't find the page you're looking for using the navigation above, please Contact Us.
In making selections for Super Doctors, MSP Communications employs a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties.
Today, the U.S. Food and Drug Administration is announcing the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s disease. This is the first FDA-approved treatment option for this indication.
Patient Perspectives in Clinical Trials
“We need you to make sure the arthritis patient voice is heard at the U.S. Food and Drug Administration (FDA)!” affirmed Suz Schrandt, the Arthritis Foundation’s director of patient engagement, in a patients’ call to action.
Surgeon General Issues New Advisory About Effects Social Media Use Has on Youth Mental Health
Today, United States Surgeon General Dr. Vivek Murthy released a new Surgeon General’s Advisory on Social Media and Youth Mental Health - PDF. While social media may offer some benefits, there are ample indicators that social media can also pose a risk of harm to the mental health and well-being of children and adolescents. Social media use by young people is nearly universal, with up to 95% of young people ages 13-17 reporting using a social media platform and more than a third saying they use social media “almost constantly.”
Nationwide Shortage of Doxycycline: Resources for Providers and Recommendations for Patient Care
The Food and Drug Administration (FDA) originally reported a shortage of some forms of doxycycline (doxycycline hyclate) and unavailability of tetracycline on January 18, 2013, caused by increased demand and manufacturing issues. FDA continues to report shortage from some, but not all, manufacturers of some dosages and forms of doxycycline hyclate and doxycycline monohydrate.
Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications. Please note: Doctors cannot pay to be included on Super Doctors® listings nor are they paid to provide input.
Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.